ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
41 hedge funds and large institutions have $88.7M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.
2,207% more capital inflows, than outflows
Capital inflows: $70.6M | Capital outflows: $3.06M
242% more funds holding
Funds holding: 12 → 41 (+29)
30.64% more ownership
Funds ownership: 9.04% → 39.68% (+31%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RTW Investments
New York
|
+$10.3M |
| 2 |
Vivo Capital
Palo Alto,
California
|
+$9M |
| 3 |
OrbiMed
New York
|
+$7.98M |
| 4 |
Logos Global Management
San Francisco,
California
|
+$7.29M |
| 5 |
Mangrove Partners
Greenwich,
Connecticut
|
+$6.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ikarian Capital
Dallas,
Texas
|
-$2.48M |
| 2 |
Boothbay Fund Management
New York
|
-$255K |
| 3 |
Renaissance Technologies
New York
|
-$210K |
| 4 |
Morgan Stanley
New York
|
-$118K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.03K |
ASLN Hedge Fund Activity: Q1 2021 in Review
41 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q1 2021, worth a combined $88.7M — up 975% from $8.25M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ASLN positions and 0 closed out — a net gain of 29 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $10.3M. The largest seller was Ikarian Capital, cutting an estimated $2.48M.
- 41 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q1 2021, up from 12 in Q4 2020.
- Funds reported $88.7M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q1 2021, up 975% quarter-over-quarter.
- 29 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q1 2021 and 0 closed out, a net change of +29 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q1 2021 was RTW Investments, an estimated $10.3M added.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q1 2021 was Ikarian Capital, an estimated $2.48M sold.
Based on aggregated 13F filings for Q1 2021.